सभी अध्ययन
सक्रिय लेकिन भर्ती नहींचरण 2हस्तक्षेपात्मक

Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)

This study is for people who have Generalized Myasthenia Gravis (MG), a condition that causes muscle weakness. Researchers are testing a new treatment called Descartes-08 CAR T-cells. This is a Phase IIb study, which means it's an early stage to see if the treatment is safe for people and if it starts to show benefits. The study will look at how well people with MG respond to this new treatment and if there are any side effects. Both people who test positive or negative for certain antibodies related to MG can take part. The main goal is to find out if Descartes-08 could be a helpful new option for managing generalized MG.

एक नजर में

स्थिति
सक्रिय लेकिन भर्ती नहीं
चरण
चरण 2
प्रायोजक
Cartesian Therapeutics
नामांकन लक्ष्य
30
प्रारंभ
04 Dec 2019
अनुमानित पूर्णता
31 मार्च 2026

यह अध्ययन किस बारे में है?

This study is exploring a new type of treatment called Descartes-08 CAR T-cells for people who have a condition called Generalized Myasthenia Gravis (MG). MG is a long-term condition that causes muscle weakness and tiredness. This happens because the body's own immune system accidentally attacks the connections between nerves and muscles.

Descartes-08 is a special kind of treatment that uses your own immune cells, called T-cells, which are then modified in a lab to specifically target and clear out certain cells thought to be involved in MG. The aim is to calm down the immune system's attack on the muscles. This particular study is in an early stage, known as Phase IIb, which means it's being tested to see how safe it is for people with MG and if it starts to show signs of being effective in improving their condition.

The researchers are keen to see if this new approach can help reduce the symptoms of MG and improve the quality of life for those living with it. While it's an investigational treatment, the hope is that it could offer a new way to manage generalized MG for some people in the future.

मुख्य निष्कर्ष

  • This study is testing a new treatment called Descartes-08 for Generalized Myasthenia Gravis.
  • It's an early-stage study (Phase IIb) to check for safety and if it helps symptoms.
  • Adults aged 18 and over with Generalized MG can be considered.
  • Both 'seropositive' and 'seronegative' MG patients are included.
  • You cannot participate if pregnant, breastfeeding, or have other serious uncontrolled illnesses.

कौन पात्र हो सकता है?

To be considered for this study, you need to be at least 18 years old and have been diagnosed with Generalized Myasthenia Gravis. Your doctor must also believe that you need ongoing medication to control your condition. Interestingly, this study includes people with MG whether they test positive or negative for certain common blood markers sometimes used to diagnose MG.

However, some people won't be able to join. For example, if you have another serious long-term illness that isn't under control, and the study doctor thinks it might make taking part risky for you. Also, if you are pregnant or breastfeeding, unfortunately, you wouldn't be able to participate in this study.

क्या यह अध्ययन आपके लिए उपयुक्त हो सकता है?

यह देखने के लिए इन त्वरित प्रश्नों का उत्तर दें कि क्या आप पात्र हो सकते हैं। यह केवल एक मार्गदर्शिका है — अंतिम निर्णय शोध टीम द्वारा लिया जाता है।.

  1. क्या आप 18 वर्ष या उससे अधिक आयु के हैं?
  2. Do you have a diagnosis of Generalized Myasthenia Gravis?
  3. Does your doctor think you need medication for your MG?
  4. क्या आप वर्तमान में गर्भवती या स्तनपान नहीं करा रही हैं?
  5. Do you NOT have any other major uncontrolled chronic illnesses?
अपने परिणाम देखने के लिए हर प्रश्न का उत्तर दें।.

भागीदारी में क्या शामिल है?

While the detailed plan for participation isn't fully described, usually taking part in a clinical trial involves a number of steps. You would first have screening appointments to check if you meet all the study's requirements. If you qualify, you would receive the Descartes-08 treatment. This type of treatment often involves collecting your specific immune cells, sending them away to be specially prepared, and then giving them back to you.

After treatment, you would likely have regular follow-up visits to check on your health, how you're responding to the treatment, and to look for any side effects. These visits might include blood tests, physical examinations, and questionnaires about your symptoms and how you are generally feeling. The exact number and frequency of visits, as well as the total length of your involvement in the study, would be fully explained to you by the study team.

संभावित जोखिम और लाभ

Participating in this study might offer a potential benefit by giving you access to a new treatment for Generalized Myasthenia Gravis that isn't widely available yet. It could potentially improve your symptoms. However, like all new treatments, there are potential risks and side effects that are not yet fully known. The study team will monitor you closely for any reactions or complications. You have the right to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

स्थान (15)

  • Profound Research
    सत्यापित पोस्टकोड
    Carlsbad, United States
  • University of California Irvine
    सत्यापित पोस्टकोड
    इरविन, संयुक्त राज्य अमेरिका
  • कोलोराडो विश्वविद्यालय एंशुट्ज़ मेडिकल कैंपस
    सत्यापित पोस्टकोड
    ऑरोरा, संयुक्त राज्य अमेरिका
  • SFM Clinical Research, LLC
    सत्यापित पोस्टकोड
    बोका रैटन, संयुक्त राज्य अमेरिका
  • Neurology Associates, P.A.
    सत्यापित पोस्टकोड
    ऑरलैंडो, संयुक्त राज्य अमेरिका
  • University of South Florida
    सत्यापित पोस्टकोड
    टाम्पा, संयुक्त राज्य अमेरिका
  • University of Augusta
    सत्यापित पोस्टकोड
    ऑगस्टा, संयुक्त राज्य अमेरिका
  • University of Kansas Medical Center Research Institute
    सत्यापित पोस्टकोड
    कैनसस सिटी, संयुक्त राज्य अमेरिका
  • Dent Neurologic Institute
    सत्यापित पोस्टकोड
    Amherst, United States
  • University of North Carolina
    सत्यापित पोस्टकोड
    चैपल हिल, संयुक्त राज्य अमेरिका
  • ओरेगन स्वास्थ्य और विज्ञान विश्वविद्यालय
    सत्यापित पोस्टकोड
    पोर्टलैंड, संयुक्त राज्य अमेरिका
  • पेंसिल्वेनिया विश्वविद्यालय
    सत्यापित पोस्टकोड
    फिलाडेल्फिया, संयुक्त राज्य अमेरिका

सामान्य प्रश्न

What is Generalized Myasthenia Gravis?

It's a long-term condition that causes weakness in muscles throughout your body, as your immune system mistakenly attacks nerve-muscle connections.

What are 'CAR T-cells'?

CAR T-cells are a special type of treatment where your own immune cells are modified to find and fight certain other cells in your body.

What does Phase IIb mean for a study?

It means the study is an early stage to check if the new treatment is safe for people and if it starts to show benefits for the condition.

Will I get 'Descartes-08' if I join?

If you meet all the study's requirements and are accepted, you will receive the Descartes-08 treatment as part of the study.

Can I join if I'm already on other MG medicines?

Yes, if your doctor thinks you need ongoing immunosuppressive medications for your MG, you can still be considered for the study.

और अधिक जानने के लिए कैसे पता करें

किसी अध्ययन में भाग लेने का निर्णय लेने से पहले हमेशा अपने जीपी या विशेषज्ञ से बात करें।.

चर्चा

समुदाय चर्चा

हमारे फोरम द्वारा संचालित community.patient.info. कृपया सम्मानजनक रहें — यह चिकित्सा सलाह नहीं है।.